Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062746/0595 | |
| Pages: | 5 |
| | Recorded: | 02/10/2023 | | |
| Attorney Dkt #: | GMI-156BUS, GMI-156BUSCN |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF INVENTOR DAVID SATIJN'S LAST NAME FROM "SATIJIN" TO SATIJN ON THE NOTICE OF RECORATION PREVIOUSLY RECORDED AT REEL: 062552 FRAME: 0390. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16069395
|
Filing Dt:
|
07/11/2018
|
|
Publication #:
|
|
Pub Dt:
|
01/24/2019
| | | | |
|
Title:
|
AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17957302
|
Filing Dt:
|
09/30/2022
|
|
Publication #:
|
|
Pub Dt:
|
10/12/2023
| | | | |
|
Title:
|
AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
|
|
|
Assignee
|
|
|
|
|
| KALVEBOD BRYGGE 43 |
| COPENHAGEN V, DENMARK DK-1560 |
|
|
Correspondence name and address
|
| |
NELSON MULLINS RILEY & SCARBOROUGH LLP
|
| |
ONE FINANCIAL CENTER
|
| |
SUITE 3500
|
| |
BOSTON, MA 02111
|
Search Results as of:
09/22/2024 01:47 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
